GAMMA Investing’s Sight Sciences SGHT Stock Holding History

GAMMA Investing’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-681	Closed	-$5.4K	–	4217
2025 Q4	$5.4K	Buy	+681	New	+$4.35K	﹤0.01%	3243

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

GAMMA Investing's SGHT Position: Q1 2026 in Review

GAMMA Investing sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 681 shares — an estimated $5.4K sold.

GAMMA Investing first reported a position in SGHT in Q4 2025 and held it in 1 quarter. The position peaked at $5.4K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

GAMMA Investing reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
GAMMA Investing sold 681 Sight Sciences shares in Q1 2026, an estimated $5.4K.
GAMMA Investing first reported a position in Sight Sciences in Q4 2025 and held it in 1 quarter.
GAMMA Investing's Sight Sciences position peaked at $5.4K in Q4 2025.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.